Adding immunomodulators to corticosteroids early can improve VKH syndrome outcomes

This study evaluated the potential advantage of adding immunomodulatory therapy to corticosteroid treatment for Vogt-Koyanagi-Harada syndrome within 3 months of syndrome onset.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553